This website is intended for an international audience, excluding the United States and Canada. View your own country’s local language website.

 

Terms of Use

Legal Notice

Lupin Ltd. (“Lupin”) is an Indian company with registered number L24100MH1983PLC029442 and registered office at Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (East), Mumbai – 400055, India.

TERMS OF USE

PLEASE READ THESE TERMS OF USE CAREFULLY. This site is owned and operated by Lupin. Lupin owns other websites, but these Terms of Use describe rules for visitors to this website and do not apply to other Lupin owned websites. You should refer to the terms of use posted on other Lupin websites when you visit them.

For valuable consideration, including your use and access of any portion of this website, you agree with the following terms and conditions as evidenced by your use and/or access of the website.

WHO TO CALL FOR AN EMERGENCY

THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR LOCAL EMERGENCY RESPONSE NUMBER IMMEDIATELY.

ABOUT THE INFORMATION ON THIS WEBSITE

This website may contain information on medical and health-related topics. This information is not meant to be a substitute for the advice provided by a qualified doctor or other medical professional. You should not use this information for diagnosing a health problem or disease but should always consult a doctor or other medical professional. Patients should always consult a medical professional, such as a doctor, to determine the proper diagnosis and what course of treatment may be appropriate for their particular situation. The materials on this website are for your general educational information only. Information you read on this website cannot replace the relationship that you have with your health care professional. Lupin does not practice medicine or provide medical services or advice and the information on this website should not be considered medical advice.

INTELLECTUAL PROPERTY

© 2021 Lupin Ltd. All Rights Reserved. All images used on this website are owned, licensed or used with permission by Lupin and its affiliates for use on this website only. Unauthorized use, copying or displaying is prohibited.

Unless specifically indicated in the content of the website, all other trademarks and service marks identifying the products or services in this website and related links or otherwise designated herein are proprietary to Lupin, its affiliates and licensers.

Many if not most of the Lupin products and services depicted in this website are patented and/or subject to pending patent in some jurisdictions. Nothing contained herein shall be construed as conferring any license or right under any Lupin patent, copyright, trademark or other rights proprietary to Lupin, or its affiliates and their respective licensers. You acknowledge that the materials on this website are proprietary to Lupin. You may only use the intellectual property on this website as expressly permitted in this Terms of Use and for no other purpose. You agree not to remove any proprietary notices or credits from any material used from this website. You also agree that all information and data maintained on this website or derived there from shall be the property of Lupin. The absence of a trademark designation on any Lupin trademark does not constitute a waiver of Lupin‘s rights concerning that trademark or any other intellectual property rights.

YOUR FEEDBACK, COMMENTS AND IDEAS

While Lupin is pleased to receive feedback, comments and ideas from visitors to this website, we want you to understand that any information that you submit through this website will be considered non-personal, non-confidential, and non-proprietary (other than personal information, as that term is defined in our Privacy Policy). If you transmit any ideas, information, concepts, know-how, techniques or materials to us through this website, you hereby grant Lupin an unrestricted, royalty-free, irrevocable license to use, reproduce, display, perform, modify, transmit and distribute them in any medium and manner, and agree that Lupin is free to use them for any purpose (commercial or non-commercial).

NO WARRANTIES

THE INFORMATION ON THIS WEBSITE IS PROVIDED “AS IS” WITHOUT ANY WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. LUPIN MAKES NO REPRESENTATION OR WARRANTY THAT THE INFORMATION CONTAINED ON THIS WEBSITE WILL BE TIMELY OR ERROR-FREE. THE INFORMATION ON THIS WEBSITE IS SUBJECT TO CHANGE WITHOUT NOTICE. LUPIN HAS NOT REVIEWED ALL THE WEBSITES THAT MAY BE LINKED TO ITS WEBSITE AND DOES NOT ENDORSE AND IS NOT RESPONSIBLE FOR THE CONTENT OF ANY OFF-SITE PAGES OR ANY OTHER WEBSITES LINKED TO THIS WEBSITE. YOUR USE OF SUCH LINKS IS AT YOUR OWN RISK.

The views and opinions reflected in the articles, publications, and case studies included in or linked with this website are not necessarily shared by Lupin, its subsidiaries, affiliates or licensers, and, while most studies are independent studies, Lupin cannot make any representation or warranties as to the reliability of study results and conclusions.

LIMITATION OF LIABILITY

UNDER NO CIRCUMSTANCES SHALL LUPIN, ITS SUBSIDIARIES, DIRECTORS, OFFICERS, EMPLOYEES, SUCCESSORS, ASSIGNS, AGENTS OR SUPPLIERS, BE LIABLE FOR ANY DIRECT, INDIRECT, PUNITIVE, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES THAT RESULTS FROM THE USE OF, OR INABILITY TO USE THIS WEBSITE OR FROM INFORMATION PROVIDED ON THIS WEBSITE. THIS LIMITATION APPLIES WHETHER THE ALLEGED LIABILITY IS BASED ON CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY OR ANY OTHER BASIS, EVEN IF LUPIN HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. BECAUSE SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL DAMAGES, LUPIN’S LIABILITY IN SUCH JURISDICTIONS SHALL BE LIMITED TO THE EXTENT PERMITTED BY LAW.

THE TOTAL LIABILITY OF LUPIN, ITS OFFICERS, DIRECTORS, SUBSIDIARIES, EMPLOYEES, SUCCESSORS, ASSIGNS, AGENTS, OR SUPPLIERS, IF ANY, FOR LOSSES OR DAMAGES SHALL BE LIMITED TO THE AMOUNT OF YOUR ACTUAL DAMAGES, NOT TO EXCEED EURO 100. THE LIMIT OF LIABILITY MAY NOT BE EFFECTIVE IN SOME COUNTRIES. IN NO EVENT SHALL LUPIN, ITS SUBSIDIARIES, DIRECTORS, OFFICERS, EMPLOYEES AGENTS, , SUCCESSORS, ASSIGNS, AGENTS, OR SUPPLIERS, BE LIABLE TO YOU FOR ANY LOSSES OR DAMAGES OTHER THAN THE AMOUNT DESCRIBED ABOVE. ALL OTHER DAMAGES, DIRECT OR INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY, OR PUNITIVE, RESULTING FROM ANY USE OF THIS WEBSITE OR MATERIALS ARE EXCLUDED EVEN IF LUPIN HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

LINKS TO OTHER WEBSITES

This website may provide links to other websites and third party-controlled materials and information. Lupin has no responsibility for the content of any other websites and is not responsible or liable for damages that may arise from the content of such websites or the use of any information you may submit to such websites. Lupin does not review, monitor or control the privacy practices of websites operated by others that may be accessed through a link on this website. These links are provided merely for your convenience.

INDEMNIFICATION

You agree to defend, indemnify and hold Lupin, its subsidiaries, directors, officers, employees, agents, suppliers and assigns harmless from and against any and all liabilities, claims and expenses, including legal fees that arise from your use of this website or its content, including without limitation, your violation of the Terms of Use. Lupin reserves the right, at our own expense, to assume the exclusive defense and control of any matter otherwise subject to indemnification by you, in which event you agree to cooperate with Lupin in asserting any available defenses.

FORWARD-LOOKING STATEMENTS

This website may contain forward-looking statements including, among other things, management’s estimates of future performance, revenue and earnings, our management’s growth objectives and our management’s ability to produce consistent operating improvements. These forward-looking statements are based on expectations as of the time the statements were made only and are subject to a number of risks and uncertainties which could cause us to fail to achieve our then-current financial projections and other expectations, such as a change in the demand for a Lupin product resulting from increased competition, a change in payer reimbursement policies, our ability to protect our intellectual property rights and general economic conditions. All information set forth in any presentation on this website is as of the date prepared and has not been updated since that date. Lupin undertakes no duty to update this information.

APPLICABLE LAWS

This website contains information about products which may or may not be available in any particular country and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications and restriction in different countries. Each country has specific laws, regulations and medical practices governing the communication of medical or other information about medical products on the Internet. Nothing herein should be construed as a solicitation or promotion of any product or of an indication of any product which is not authorized by the laws and regulations of the country where the reader resides.

These Terms of Use, The Privacy Policy and the use of this website are governed by the laws of England. Any and all legal action relating to this website shall be brought exclusively in the courts of competent jurisdiction in London. Notwithstanding the foregoing, Lupin is entitled to apply for injunctive remedies (or an equivalent of urgent legal relief) in any jurisdiction.

OTHER RULES ABOUT THIS WEBSITE

In addition to the rules in these Terms of Use and the Privacy Policy, you may be subject to additional terms that may apply when you access particular services or materials on certain areas in this website, such as when you purchase enhanced services, or by following a link from this website. Please read Lupin’s Privacy Policy to learn how we protect and use information that we gather through this website.

Your obligations under this section and the sections called “Your Feedback”, “Intellectual Property”, “Indemnification”, “No Warranties” and “Limitation of Liability” will survive termination of these Terms of Use.

If any provision of these Terms of Use or the Privacy Policy is found to be invalid by any court having competent jurisdiction, the invalidity of such provision shall not affect the validity of the remaining provisions of these Terms of Use or the Privacy Policy, which shall remain in full force and effect. No waiver of any of these Terms of Use or the Privacy Policy shall be deemed a further or continuing waiver of such term or condition or any other term or condition.

Your use and access to this website indicates your understanding and agreement with Lupin’s Privacy Policy that can be accessed here.

What’s your NDM story?

speech

Share your story of your journey with NDM here

You are free to share your story in writing, video, audio, painting, or any other form that helps you tell your story about your journey with NDM.

Foods to avoid on a low-potassium diet*

  • Fruit1,2
  • Vegetables1,2
  • Beans/legumes1,3
  • Other1-3
  • Avocado
  • Artichoke
  • Baked beans
  • Bran cereal
  • Apricots
  • Beetroot
  • Kidney beans
  • Dairy (eg yoghurt, milk)
  • Bananas
  • Brussel sprouts
  • Lentils
  • Nuts
  • Dried fruits eg dates, raisins and prunes
  • Broccoli (cooked)
  • Brown rice
  • Grapefruit
  • Okra
  • Salt substitutes
  • Kiwi
  • Parsnip
  • Wholewheat bread and pasta
  • Mango
  • Potatoes (processed or with skin on)
  • Melons
  • Cooked spinach
  • Nectarines
  • Tomato (concentrated, eg. Tomato puree)
  • Oranges and orange juice
  • Papaya
  • Pomegranate and pomegranate juice
  • Fruit1,2

    Avocado

    Apricots

    Bananas

    Dried fruits eg dates, raisins and prunes

    Grapefruit

    Kiwi

    Mango

    Melons

    Nectarines

    Oranges and orange juice

    Papaya

    Pomegranate and pomegranate juice

  • Vegetables1,2

    Artichoke

    Beetroot

    Brussel sprouts

    Broccoli (cooked)

    Okra

    Parsnip

    Potatoes (processed or with skin on)

    Cooked spinach

    Tomato (concentrated, eg. Tomato puree)

  • Beans/legumes1,3

    Baked beans

    Kidney beans

    Lentils

  • Other1-3

    Bran cereal

    Dairy (eg yoghurt, milk)

    Nuts

    Brown rice

    Salt substitutes

    Wholewheat bread and pasta

*Meat and fish contain a moderate amount of potassium but they are an important source of protein so shouldn’t be avoided; Dairy products contain potassium but are an important source of calcium so should be consumed in moderation
References
  • WebMD. Low-potassium diet: what to know? Available at: https://www.webmd.com/food-recipes/low-potassium-diet-foods ; Accessed March 2021
  • St Georges Kidney Patients Association. Eating on a low potassium diet. Available at: https://www.sgkpa.org.uk/main/eating-well-on-a-low-potassium-diet-2 ; Accessed March 2021
  • NHS. Information for people on a low potassium diet. Available at: https://www.nth.nhs.uk/content/uploads/2019/02/PIL1061-Information-for-people-following-a-low-potassium-diet-Final-11.02.19-LP.pdf ; Accessed March 2021
  • NDM type1
  • Symptoms2,3
  • Which type of ion channel? 2,3
  • How is it inherited?2,3
  • Thomsen myotonia congenita

    (also called Thomsen myotonia or autosomal dominant myotonia congenita)
  • Lower limbs tend to be more affected, although can also affect the arms, hands and face. Stiffness may be worse when you first try to move after a period of inactivity, and may ease as you ‘warm up’.
  • Chloride (Cl-)
  • Autosomal dominant
  • Becker myotonia congenita

    (also called Becker myotonia, Becker disease, generalized myotonia, recessive generalized myotonia or autosomal recessive myotonia congenita
  • Lower limbs tend to be more affected, although can also affect the arms, hands and face. Stiffness may be worse when you first try to move after a period of inactivity, or if you are startled, and may ease as you ‘warm up’. Sometimes people with Becker myotonia congenita experience temporary weakness after an episode of myotonia.
  • Chloride (Cl-)
  • Autosomal recessive
  • Paramyotonia congenita

    (Also called Eulenburg disease, paralysis periodica paramyotonia, paramyotonia congenita of von Eulenburg, PMC or von Eulenburg’s disease)
  • Myotonia mainly affects hands and face and gets worse with exercise. Cold is also a key trigger of myotonia, and muscle weakness after an episode of myotonia may last hours or sometimes days.
  • Sodium (Na+)
  • Autosomal dominant
  • Sodium channel myotonia, SCM:

    myotonia permanens and myotonia fluctuans, acetazolamide-responsive myotonia (ARM) previously known as Potassium aggravated myotonias (PAM)
  • Potassium-aggravated myotonia is a rare form of NDM that affects all areas of the body. Myotonia attacks are triggered by eating potassium-rich foods. Symptoms may fluctuate widely from day to day (myotonia fluctuans) or are constant and severe (myotonia permanens).
  • Sodium (Na+)
  • Autosomal dominant
  • Other closely related sodium disorders with myotonia

    (including hyperkalemic paralysis or hyperPP)
  • Myotonia is usually mild, and often involves the eyelids, hands, and tongue. Attacks of weakness can occur at any time and are commonly triggered by rest following exercise, fasting, eating potassium-rich foods or stress.
  • Sodium (Na+)
  • Autosomal dominant
References
  • Stunnenberg B. Muscle Nerve. 2020 Oct; 62(4): 430–444
  • Hahn C, Salajegheh MK. Iran J Neurol 2016;15:46–53
  • Matthews E, et al. Brain 2010:133; 9–22
  • NDM type1

    Thomsen myotonia congenita

    (also called Thomsen myotonia or autosomal dominant myotonia congenita)

    Becker myotonia congenita

    (also called Becker myotonia, Becker disease, generalized myotonia, recessive generalized myotonia or autosomal recessive myotonia congenita

    Paramyotonia congenita

    (Also called Eulenburg disease, paralysis periodica paramyotonia, paramyotonia congenita of von Eulenburg, PMC or von Eulenburg’s disease)

    Sodium channel myotonia, SCM:

    myotonia permanens and myotonia fluctuans, acetazolamide-responsive myotonia (ARM) previously known as Potassium aggravated myotonias (PAM)

    Other closely related sodium disorders with myotonia

    (including hyperkalemic paralysis or hyperPP)

  • Symptoms2,3

    Lower limbs tend to be more affected, although can also affect the arms, hands and face. Stiffness may be worse when you first try to move after a period of inactivity, and may ease as you ‘warm up’.

    Lower limbs tend to be more affected, although can also affect the arms, hands and face. Stiffness may be worse when you first try to move after a period of inactivity, or if you are startled, and may ease as you ‘warm up’. Sometimes people with Becker myotonia congenita experience temporary weakness after an episode of myotonia.

    Myotonia mainly affects hands and face and gets worse with exercise. Cold is also a key trigger of myotonia, and muscle weakness after an episode of myotonia may last hours or sometimes days.

    Potassium-aggravated myotonia is a rare form of NDM that affects all areas of the body. Myotonia attacks are triggered by eating potassium-rich foods. Symptoms may fluctuate widely from day to day (myotonia fluctuans) or are constant and severe (myotonia permanens).

    Myotonia is usually mild, and often involves the eyelids, hands, and tongue. Attacks of weakness can occur at any time and are commonly triggered by rest following exercise, fasting, eating potassium-rich foods or stress.

  • Which type of ion channel? 2,3

    Chloride (Cl-)

    Chloride (Cl-)

    Sodium (Na+)

    Sodium (Na+)

    Sodium (Na+)

  • How is it inherited?2,3

    Autosomal dominant

    Autosomal recessive

    Autosomal dominant

    Autosomal dominant

    Autosomal dominant

References
  • Stunnenberg B. Muscle Nerve. 2020 Oct; 62(4): 430–444
  • Hahn C, Salajegheh MK. Iran J Neurol 2016;15:46–53
  • Matthews E, et al. Brain 2010:133; 9–22